Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol to invest $2 mil. in Houghten drug discovery collaboration by project end, lawsuit discloses.

Executive Summary

BRISTOL TO INVEST $2 MIL. IN HOUGHTEN DRUG DISCOVERY COLLABORATION upon completion of the project, which applies Houghten Pharmaceuticals Inc. subsidiary ChromaXome's combinatorial biology to Bristol-Myers Squibb's microbe library for screening of new drug leads, according to statements made in an Oct. 7 lawsuit. The wrongful termination of employment suit was brought by ChromaXome's founders against Houghten and filed in San Diego federal court.
UsernamePublicRestriction

Register

PS029063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel